Contact
searchSearch
HMP Global
Teaching Collection

The Stenotic Aortic Valve (Part I)

Morton J. Kern, MD, MSCAI, FACC, FAHA
06/18/2020

Related Content

Aortic Valve Stenosis
Same-Day Hospital Discharge is Safe in Selected Patients After TAVI
02/20/2026
Munich, Germany – With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at the EAPCI Summit 2026.1...
Munich, Germany – With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at the EAPCI Summit 2026.1...
Munich, Germany – With careful...
02/20/2026
Cath Lab Digest
GUIDEWIRES
The New Stedi Extra Support Guidewire, Designed for Use in TAVR
01/23/2026
Tanvir Bajwa, MD
Our program treats approximately 700 transcatheter aortic valve replacement (TAVR) patients a year and has implanted over 4,000 Evolut (Medtronic) TAVRs.
Our program treats approximately 700 transcatheter aortic valve replacement (TAVR) patients a year and has implanted over 4,000 Evolut (Medtronic) TAVRs.
Our program treats approximately...
01/23/2026
Cath Lab Digest
Cardiac Models
University of Missouri Researchers Create New Way to Study Heart Valve Stiffness
12/02/2025
By characterizing the progression of aortic valve calcification in this “humanized” model over time, the stage is now set to test potential treatments for the condition, which could lead to medicine to stop or reverse calcium buildup in the...
By characterizing the progression of aortic valve calcification in this “humanized” model over time, the stage is now set to test potential treatments for the condition, which could lead to medicine to stop or reverse calcium buildup in the...
By characterizing the...
12/02/2025
Cath Lab Digest
Heart Valve Clinical Trials
Meril Life Sciences Presents One-Year Outcomes From the LANDMARK Randomized Controlled Trial at PCR London Valves 2025
12/02/2025
The LANDMARK trial is the first randomized non-inferiority trial comparing the balloon-expandable Myval THV series with other contemporary balloon-expandable Sapien THV series and self-expandable Evolut THV series in patients with symptomatic...
The LANDMARK trial is the first randomized non-inferiority trial comparing the balloon-expandable Myval THV series with other contemporary balloon-expandable Sapien THV series and self-expandable Evolut THV series in patients with symptomatic...
The LANDMARK trial is the first...
12/02/2025
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Endovascular Devices
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML)
03/19/2026
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026...
03/19/2026
Vascular Disease Management
Neurovascular acquisitions
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/11/2026
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
Scientia's novel access platform...
03/11/2026
Cath Lab Digest
EggNest (Egg Medical)
Clinical Trial Update
Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection
03/10/2026
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we...
03/10/2026
EP Lab Digest
CathWorks FFRangio
Fractional Flow Reserve
Late-Breaking Trial: U.S. Cohort of 4,000+ CathWorks FFRangio Patients Shows 2-Year Outcomes Comparable to Pressure Wire–Guided PCI
03/08/2026
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
"This first look at contemporary...
03/08/2026
Cath Lab Digest
Heart Failure
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
03/04/2026
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
Dr. Amish Raval reported that...
03/04/2026
Cath Lab Digest
Heart Failure
Relief Cardiovascular Reports Positive First-in-Human Data for Device-Based Decongestion Therapy in Heart Failure Patients
03/04/2026
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
"The RELIEF-FIH study provides...
03/04/2026
Cath Lab Digest
Amputation Prevention
Researchers Develop New Oxygen-Delivering Gel Designed to Help Wounds Heal Before They Progress to Limb Loss
02/23/2026
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
A wound that remains open for...
02/23/2026
Cath Lab Digest
Nutrition
People Whose Sugar Intake Was Restricted Before Birth and In Early Childhood Had Markedly Lower Rates of Heart Disease Later In Life 
02/23/2026
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
Limiting sugar consumption...
02/23/2026
Cath Lab Digest
VentiV Mechanical Thrombectomy system illustration
Thrombectomy
FDA Clearance for VentiV Mechanical Thrombectomy System Brings New “Pulse” Platform to Peripheral Clot Removal
02/23/2026
SALT LAKE CITY, UT  — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. Blood clot removal...
SALT LAKE CITY, UT  — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. Blood clot removal...
SALT LAKE CITY, UT ...
02/23/2026
Cath Lab Digest
Acute Coronary Syndromes
Acute Coronary Events Registry Provides Insights Into Sex-Specific Differences
02/20/2026
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
Munich, Germany – Preliminary...
02/20/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use